RETRACTED: Effect of captopril, losartan, and bradykinin on early steps of insulin action (Retracted article. See vol. 65, pg. 1128, 2016)

被引:100
作者
Carvalho, CRO [1 ]
Thirone, ACP [1 ]
Gontijo, JAR [1 ]
Velloso, LA [1 ]
Saad, MJA [1 ]
机构
[1] UNIV ESTADUAL CAMPINAS, FCM, DEPT CLIN MED, BR-13081970 CAMPINAS, BRAZIL
关键词
D O I
10.2337/diabetes.46.12.1950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin initiates its metabolic and growth-promoting effects by binding to the a subunit of its receptor, thereby activating the kinase in the beta subunit. This event leads to tyrosyl phosphorylation of its cytosolic substrate, insulin receptor substrate 1 (IRS-1), which in turn associates with and activates phosphatidylinositol (PI) 3-kinase. The clinical use of ACE inhibitors has been associated with increased insulin sensitivity. However, the exact molecular mechanism is unknown. In the present study, we examined the phosphorylation status of the insulin receptor and IBS-I, as well as the association between IRS-1 and PI 3-kinase in the liver and muscle of 20-month-old rats treated acutely with captopril, using immunoprecipitation with antipeptide antibodies to the insulin receptor and IRS-1, and immunoblotting with antiphosphotyrosine and anti-PI 3-kinase antibodies. Insulin stimulation increased receptor autophosphorylation to 462 +/- 253% (P < 0.05) in the liver and 697 +/- 78% (P < 0.001) in the muscle of ACE inhibitor-treated rats. There were also increases to 250 +/- 17% (P < 0.001) and 280 +/- 50% (P < 0.05) in the insulin-stimulated IRS-1 phosphorylation levels in the liver and muscle, respectively, of animals treated with captopril. The insulin-stimulated IRS-1 association with PI 3-kinase rose to 305 +/- 20% (P < 0.001) in Liver and 267 +/- 48% (P < 0.05) in muscle. Losartan, an ANG receptor blocker, had no significant effect on insulin-stimulated IRS-1 phosphorylation in both tissues. The acute administration of bradykinin increased insulin-stimulated tyrosine phosphorylation of the insulin receptor and IRS-1 in the liver and muscle. These data demonstrate that ACE inhibitors modulate the early steps of insulin signaling, and that this effect may be simulated by the administration of bradykinin.
引用
收藏
页码:1950 / 1957
页数:8
相关论文
共 62 条
[1]   HYPOGLYCEMIA INDUCED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES RECEIVING SULFONYLUREA THERAPY [J].
ARAUZPACHECO, C ;
RAMIREZ, LC ;
RIOS, JM ;
RASKIN, P .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (06) :811-813
[2]   PHOSPHATIDYLINOSITOL 3'-KINASE IS ACTIVATED BY ASSOCIATION WITH IRS-1 DURING INSULIN STIMULATION [J].
BACKER, JM ;
MYERS, MG ;
SHOELSON, SE ;
CHIN, DJ ;
SUN, XJ ;
MIRALPEIX, M ;
HU, P ;
MARGOLIS, B ;
SKOLNIK, EY ;
SCHLESSINGER, J ;
WHITE, MF .
EMBO JOURNAL, 1992, 11 (09) :3469-3479
[3]  
BERNE C, 1991, J INTERN MED, V229, P119
[4]   ESTIMATES OF INVIVO INSULIN ACTION IN MAN - COMPARISON OF INSULIN TOLERANCE-TESTS WITH EUGLYCEMIC AND HYPERGLYCEMIC GLUCOSE CLAMP STUDIES [J].
BONORA, E ;
MOGHETTI, P ;
ZANCANARO, C ;
CIGOLINI, M ;
QUERENA, M ;
CACCIATORI, V ;
CORGNATI, A ;
MUGGEO, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :374-378
[5]   ANGIOTENSIN-II RECEPTOR SUBTYPES - CHARACTERIZATION, SIGNALING MECHANISMS, AND POSSIBLE PHYSIOLOGICAL IMPLICATIONS [J].
BOTTARI, SP ;
DEGASPARO, M ;
STECKELINGS, UM ;
LEVENS, NR .
FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) :123-171
[6]   Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats [J].
Carvalho, CRO ;
Brenelli, SL ;
Silva, AC ;
Nunes, ALB ;
Velloso, LA ;
Saad, MJA .
ENDOCRINOLOGY, 1996, 137 (01) :151-159
[7]   PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION IS REQUIRED FOR INSULIN STIMULATION OF PP70 S6 KINASE, DNA-SYNTHESIS, AND GLUCOSE-TRANSPORTER TRANSLOCATION [J].
CHEATHAM, B ;
VLAHOS, CJ ;
CHEATHAM, L ;
WANG, L ;
BLENIS, J ;
KAHN, CR .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4902-4911
[8]  
CHOU CK, 1987, J BIOL CHEM, V262, P1842
[9]   INHIBITION OF THE TRANSLOCATION OF GLUT1 AND GLUT4 IN 3T3-L1 CELLS BY THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN [J].
CLARKE, JF ;
YOUNG, PW ;
YONEZAWA, K ;
KASUGA, M ;
HOLMAN, GD .
BIOCHEMICAL JOURNAL, 1994, 300 :631-635
[10]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND INSULIN SENSITIVITY - METABOLIC EFFECTS IN HYPERTENSION, DIABETES, AND HEART-FAILURE [J].
DONNELLY, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S38-S44